The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome

American Journal of Gastroenterology

Volumn 104, Issue 6, 2009, Pages 1420-1425

  Muratori, Paolo ^a   Granito, Alessandro ^a   Pappas, Georgios ^a   Pendino, Gaspare M ^b   Quarneti, Chiara ^a   Cicola, Ronny ^a   Menichella, Rita ^a   Ferri, Silvia ^a   Cassani, Fabio ^a   Bianchi, Francesco B ^a   Lenzi, Marco ^a   Muratori, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Divisione di Medicina 1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; MITOCHONDRION ANTIBODY; STEROID; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SEROLOGY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; PROGNOSIS; RADIOGRAPHY, ABDOMINAL; RETROSPECTIVE STUDIES; SYNDROME; YOUNG ADULT;

EID: 66949164411     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.126     Document Type: Article

References (39)

1. Vergani D, Mieli-Vergani G. The impact of autoimmunity on hepatocytes. Semin Liver Dis 2007;27:140-51.
2. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008;47:737-45.
3. Muratori L, Granito A, Muratori P et al. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis 2008;12:261-76; vii.
4. Bernstein RM, Neuberger JM, Bunn CC et al. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol 1984;55:553-60.
5. Kurki P, Miettinen A, Linder E et al. Diferent types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance. Gut 1980;21:878-84.
6. Vergani D, Alvarez F, Bianchi FB et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-83.
7. Czaja AJ, Carpenter HA, Santrach PJ et al. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol 996;24:52-9.
8. Chazouilleres O, Wendum D, Serfaty L et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28:296-301.
9. Lohse AW, zum Buschenfelde KH, Franz B et al. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999;29:1078-84.
10. Muratori L, Cassani F, Pappas G et al. The hepatitic/ cholestatic" overlap" syndrome: an Italian experience. Autoimmunity 2002;35:565-8.
11. Gheorghe L, Iacob S, Gheorghe C et al. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur J Gastroenterol Hepatol 2004;16:585-92.
12. Heurgue A, Vitry F, Diebold M et al. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol 2007;31:17-25.
13. Gunsar F, Akarca U, Ersoz G et al. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Hepatogastroenterology 2002;49:1195-200.
14. Usta Y, Gurakan F, Akcoren Z et al. An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood. World J Gastroenterol 2007;13:2764-7.
15. Talwalkar JA, Keach JC, Angulo P et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 2002;97:1191-7.
16. Silveira MG, Talwalkar JA, Angulo P et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 2007;102:1244-50.
17. Joshi S, Cauch-Dudek K, Wanless IR et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 2002;35:409-3.
18. Suzuki Y, Arase Y, Ikeda K et al. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. J Gastroenterol Hepatol 2004;9:699-706.
19. Wagle SD, Jagtap SP, Wadia F. Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Indian J Gastroenterol 2004;23:70-1.
20. Patel N, Amarapurkar D, Amarapurkar A. Primary biliary cirrhosis and autoimmune hepatitis switch over: report of 2 cases. Trop Gastroenterol 2005;26:136-8.
21. Wu CH, Wang QH, Tian GS et al. Clinical features of the overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis: retrospective study. Chin Med J (Engl) 2006;119:238-41.
22. Kanda T, Yokosuka O, Hirasawa Y et al. Occurrence of autoimmune hepatitis during the course of primary biliary cirrhosis: report of two cases. Dig Dis Sci 2006;51:45-6.
23. Gossard AA, Lindor KD. Development of autoimmune hepatitis in primary biliary cirrhosis. Liver Int 2007;27:1086-90.
24. Czaja AJ Treatment of autoimmune hepatitis. Semin Liver Dis 2002;22:365-78.
25. Levy C, Lindor KD. Management of osteoporosis, fat-soluble vitamin defi-ciencies, and hyperlipidemia in primary biliary cirrhosis. Clin Liver Dis 2003;7:901-10.
26. Chazouilleres O, Wendum D, Serfaty L et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006;44:400-6.
27. Alvarez F, Berg P, Bianchi F et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
28. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005-13.
29. Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006;130:715-20.
30. Czaja AJ Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-97.
31. Muratori P, Muratori L, Guidi M et al. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis 2005;40:501-7
32. Muratori P, Muratori L, Gershwin ME et al. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol 2004;135:154-8.
33. Zauli D, Ghetti S, Grassi A et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 1997;25:1105-7.
34. Al-Chalabi T Portmann BC, Bernal W et al. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther 2008;28:209-20.
35. Kanzler S, Bozkurt S, Herkel J et al. Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome). Dtsch Med Wochenschr 2001;126:450-6.
36. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
37. Pappas G, Granito A, Bianchi FB. Systemic lupus erythematosus. N Engl J Med 2008;358:2412; author reply 2413.
38. Czaja AJ Muratori P, Muratori L et al. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 2004;24:322-9.
39. O'Brien C, Joshi S, Feld JJ et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008;48:550-6.